ALX ONCOLOGY HOLDINGS INC (ALXO) › Weighted Average Diluted SharesALX ONCOLOGY HOLDINGS INC (ALXO) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2020-12-31: 18.49M2021-12-31: 40.31M2022-12-31: 40.70M2023-12-31: 42.99M2024-12-31: 52.17M2025-12-31: 53.66M53.66M2020-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3153.66M+2.8%2026-03-09From 2025-01-012024-12-3152.17M+21.4%2026-03-09From 2024-01-012023-12-3142.99M+5.6%2026-03-09From 2023-01-012022-12-3140.70M+1.0%2025-03-06From 2022-01-012021-12-3140.31M+118.1%2024-03-07From 2021-01-012020-12-3118.49M—2023-03-09From 2020-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)